Eighteen (90.0%) patients with adeno-NEPC and 27 (58.7%) with adeno-PCa had high prostate-specific antigen (PSA) levels > 20 ng/L) at the time of diagnosis. The gene discussed is KLK3; the disease is posterior cortical atrophy.